Due to the ongoing Covid-19 pandemic, the EURION Cluster Annual Meeting 2022 was held virtually again this year, taking place on 20-21 January 2022.
Open to the public, the morning session on 20 January provided highlights on the activities and results from each of the eight EURION Cluster projects. The projects are developing new testing and screening methods to identify endocrine disrupting chemicals (EDCs). EDCs are chemicals which mimic natural hormones, that can produce adverse effects by disrupting the body’s endocrine (hormone) system. This hormone disruption can affect brain development, fertility, thyroid function, metabolism and therefore lead to medical disorders such as obesity, diabetes, breast cancer, non-alcoholic fatty liver disease (NAFLD), irregular menstrual cycles and endometriosis, to name but a few.
To learn more about these innovative projects and hear their latest research activities, please check out the Project Highlights from each of the Coordinators presented at the EURION Cluster Annual Meeting in January 2022.